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• Over 27 viruses found in human semen and sexual
transmission confirmed in non-STIs, including Zika,
Ebola, Chikungunya, and Dengue1.
• Viruses can pass the blood‐testis barrier in the
presence of systemic/local inflammation and may
persist in reproductive tract as a reservoir due to
immunological privilege required for sperm survival2.
• Previous studies have found that SARS-CoV-2 is likely
capable of infecting the testes due to high expression of
ACE2 and TMPRSS2, proteins necessary for viral
attachment and entrance, in sperm cells, Leydig cells,
and Sertoli cells3.
• Li, Jin, & Bao (2020) found evidence of SARS-CoV-2 in
semen of six (15.7%) patients out of 38 total, with 4
patients in the acute stage and 2 already recovered4.

• Compared to the baseline Ct values for the stock virus, we found that the N1 and N2 values did
change significantly72 hours following the addition of and incubation with seminal fluid for 1 hour at
34°C (Table 1).
• The Ct values for N1 and N2 do not appear to be substantially lower after mixing with sperm for 1
hour at 34°C but were reduced after 72 hours of incubation (Table 1)
• For the sample control, seminal fluid alone appeared to cause no cytotoxicity (Figure 1B).
• Infectious virus (plaques and CPE) found after incubation with seminal fluid (Figure 1 and Figure 2).

• Detection of infectious virus after mixing suggests that
SF is a suitable environment for SARS-CoV-2 to
survive.
• Sperm appears to be capable of infection by SARSCoV-2.
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Methodology
Part I
• Uninfected seminal fluid (SF) from biobank samples
collected from men prior to the COVID-19 pandemic were
pooled and spiked with SARS-CoV-2 stock virus (1.7 x
106 viral particles/mL) for 1 hour at 34°C.
• The baseline Ct of the virus was measured via RT-qPCR.
• After the initial incubation with SF, the virus/SF mixture
was tested via RT-qPCR, plated on Vero E6 cells in
triplicate and a plaque assay was conducted.
• The mixture was added to an additional CPE plate,
allowed to incubate for an hour, and then removed and
washed thoroughly before new media was added.
• Media from the CPE plate was collected for RT-qPCR 3
dpi and photographed for cytotoxicity.
• The CDC 2019-Novel Coronavirus (2019-nCoV) RealTime RT-PCR Diagnostic Panel was used to test for
presence the viral genetic markers Nucleoprotein 1 and
2, indicating current infection.
Part II
• A cryopreserved, whole semen sample obtained from a
sperm bank was infected with stock virus at an MOI of
0.5 before incubating for 1 hour at 34°C.
• After incubation, the mixture was washed twice to
remove the virus and resuspended in sterile media
before testing via RT-qPCR and plating on Vero E6 cells.
• The Ct value was measured after 72 hours and
cytotoxicity was photographed.
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Recommendations

A

• Is SARS-CoV-2 present in the semen of men with
active infections?
• Is virus present in seminal fluid, sperm, or both?
• Is presence influenced by infection severity, including
fever?
• What are the impacts of SARS-CoV-2 infection on
sperm parameters?
• Does infection impact spermatogenesis by affecting the
function of Sertoli and Leydig cells?
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Table 1: RT-qPCR results showing quantitative
measurement of genetic markers for CoV-2 at
different timepoints with seminal fluid and sperm.
N1= Nucleoprotein 1; N2= Nucleoprotein 2.

Undiluted

B 1: A) The plaques (small white circles) are visible in
Figure
dilutions of a plaque assay on Vero E6 cells conducted after
SARS-CoV-2 viral stock was mixed and incubated with SF at
at 34°C. SF: Seminal fluid.
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Source: Almeida et al. (2020) “The Cellular Impact of the ZIKA Virus on
Male Reproductive Tract Immunology and Physiology”
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Figure 2: Cytotoxicity dilution
on Vero E6 cells after stock
virus was mixed with SF,
incubated for 1 hour
at at
-5
10
34°C, washed and incubated
for 72 hours at 37°C.
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